Primary liver cancer is cancer that started in the liver. This section is mainly about the most common type of liver cancer, hepatocellular carcinoma (HCC). If you have cancer that started in another ...

Uncovering the molecular drivers of liver cancer Date: April 15, 2025 Source: Hiroshima University Summary: Researchers discover that inflammation and aging contribute to non-viral liver cancer ...

Lung cancer liver metastases are tumors that form in the liver from cancer cells that have broken away from the primary cancer and spread through the blood or lymphatic system. The liver is a common ...

Immunotherapy is the use of medicines that help a person’s own immune system find and destroy cancer cells. It can be used to treat some people with liver cancer. An important part of the immune ...

The stage of primary liver cancer tells you how big it is and whether it has spread to other parts of the body. This helps your doctor recommend the best treatment for you. Primary liver cancer is ...

New research from the Centenary Institute has found that switching off a specific protein in liver cells may help prevent the early development of liver cancer. More than 3,000 people are ...

One liver cancer, hepatocellular carcinoma (HCC), is associated with CLD in about 15%–25% of cases.While increasing awareness and screening of cancers has improved the ability to detect liver ...

MARTINSBURG, WV — WVU Medicine Berkeley Medical Center is now offering a new treatment for liver cancer, according to a community announcement. Y-90 radioembolization is a minimally invasive ...

Symptoms that may indicate end stage liver cancer include increased fatigue, abdominal pain, and jaundice, which is the yellowing of the skin and mucus membranes. If a person is nearing the end of ...

Liver cancer is the fourth leading cause of cancer-related deaths worldwide. According to estimates by the World Health Organization, more than one million people are expected to die from this disease ...

Liver cancer, predominantly hepatocellular carcinoma (HCC), remains one of the most aggressive and leading causes of cancer-related deaths worldwide. The liver cancer diagnostics market is critical ...